| Produktname | Sitagliptin |
|---|---|
| CAS-Nummer | 486460-32-6 |
| Molekülformel | C16H15F6N5O |
| Molekulargewicht | 407.31 g/mol |
| Aussehen | Weißes bis cremefarbenes kristallines Pulver |
| Analyse (HPLC) | ≥99% |
| Trocknungsverlust | ≤0,5% |
| Verbrennungsrückstand | ≤0,1% |
| Schwermetalle | ≤ 10 ppm |
| Schmelzpunkt | ~203-207°C |
| Spezifische Rotation | [α]D20 = -10° to -12° (c=1, methanol) |
| Technische Daten | 99% |
Brauchst du Hilfe? Kontaktieren Sie unser Team

Sitagliptin is one of the most widely prescribed DPP-4 inhibitors on the market, and for good reason: it helps type 2 diabetes patients manage blood glucose without the dramatic peaks and troughs that come with some older therapies. By selectively blocking the DPP-4 enzyme, it extends the half-life of incretin hormones like GLP-1, which in turn boosts insulin release when glucose is high and keeps glucagon secretion in check. The result is a smoother, more physiological control of post-meal blood sugar—exactly what clinicians and patients are looking for.
We supply sitagliptin as a high-purity API (≥99% by HPLC) in its base form, ideal for formulation into oral tablets or combination therapies. Every batch is manufactured under strict quality controls and shipped with a complete COA, so you know exactly what you’re getting. Whether you’re planning a small pilot run or gearing up for commercial-scale production, we can match your volume—from 1 kg to metric tons—with reliable lead times and global logistics.